Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BAY 3375968 |
Synonyms | |
Therapy Description |
BAY 3375968 is an anti-CCR8 monoclonal antibody, which potentially reduces CCR8-positive regulatory T-cells in the tumor microenvironment through antibody dependent cellular cytotoxicity (ADCC) and cellular phagocytosis (ADCP) (Cancer Res 2022;82(12_Suppl):Abstract nr 2866). |